Associated Papers
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors.
Singh S et al.
Nature, 2025
40836083 (PubMed )
Supplement: 41586_2025_9433_MOESM4_ESM.zip › 2024-07-15654B-s4 › Table_S5_052925.xlsx › Tab_4-zscore_CCNB1_C_T
BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.
Alakus H et al.
Journal of Translational Medicine, 2015
25889843 (PubMed )
Supplement: 12967_2015_485_MOESM1_ESM.xlsx › Table_S5
Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab.
Cho J et al.
Molecular Cancer, 2014
24894453 (PubMed )
Supplement: 1476-4598-13-141-S4.xlsx › coding
Select a paper to view details